Estradiol hemisuccinate: Difference between revisions
Created page with "thumb|right|Chemical structure of Estradiol, the parent compound of Estradiol Hemisuccinate. '''Estradiol hemisuccinate''' is a chemical compound deri..." |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|A detailed overview of Estradiol hemisuccinate}} | |||
{{Drugbox | |||
| Verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Estradiol succinate.svg | |||
| width = 200px | |||
| image2 = <!-- Optional second image --> | |||
| width2 = <!-- Width of second image --> | |||
| IUPAC_name = (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol 3-(hydrogen succinate) | |||
| CAS_number = 123-94-4 | |||
| ATC_prefix = G03 | |||
| ATC_suffix = CA03 | |||
| PubChem = 5282388 | |||
| DrugBank = DB13945 | |||
| ChemSpiderID = 4447590 | |||
| UNII = 4TI98Z838E | |||
| KEGG = D04078 | |||
| ChEBI = 5013 | |||
| ChEMBL = 1200488 | |||
| C=22 | |||
| H=28 | |||
| O=5 | |||
| smiles = C[C@]12CC[C@H]3[C@@H]4CCC(=O)C=C4C[C@@H]3[C@@H]1CC[C@H]2O.C(=O)(C(=O)O)CC(=O)O | |||
| StdInChI = 1S/C18H24O2.C4H6O4/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20;5-3(6)1-2-4(7)8/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3;1-2H2,(H,5,6)(H,7,8)/t14-,15-,16+,17+,18+;/m1./s1 | |||
| StdInChIKey = QXHDGZCNVAXXRC-APJZJYQMSA-N | |||
}} | |||
'''Estradiol hemisuccinate''' is a | '''Estradiol hemisuccinate''' is a [[synthetic]] [[estrogen]] and a [[derivative]] of [[estradiol]], a naturally occurring [[hormone]] in the human body. It is used in [[hormone replacement therapy]] (HRT) and for other medical purposes. Estradiol hemisuccinate is an [[ester]] of estradiol, specifically the 3-hemisuccinate ester, which modifies the solubility and pharmacokinetics of the parent hormone. | ||
== | ==Pharmacology== | ||
Estradiol hemisuccinate | Estradiol hemisuccinate acts as an [[agonist]] of the [[estrogen receptor]], mimicking the effects of endogenous estradiol. It is used to treat symptoms associated with [[menopause]], such as [[hot flashes]], [[vaginal atrophy]], and [[osteoporosis]]. The hemisuccinate ester form allows for different routes of administration, including oral and parenteral, and can influence the duration of action of the drug. | ||
== Medical Uses == | ==Medical Uses== | ||
Estradiol hemisuccinate is used in | Estradiol hemisuccinate is primarily used in hormone replacement therapy for menopausal women. It helps alleviate symptoms of estrogen deficiency and can also be used in the treatment of certain types of [[breast cancer]] and [[prostate cancer]]. | ||
==Side Effects== | |||
Common side effects of estradiol hemisuccinate include [[nausea]], [[headache]], [[breast tenderness]], and [[weight gain]]. Long-term use of estrogen therapy has been associated with an increased risk of [[breast cancer]], [[endometrial cancer]], and [[cardiovascular disease]]. | |||
==Chemistry== | |||
The chemical structure of estradiol hemisuccinate is characterized by the addition of a succinate group to the estradiol molecule. This modification increases the water solubility of the compound, which can be advantageous for certain formulations and routes of administration. | |||
== | ==See Also== | ||
Estradiol | * [[Estradiol]] | ||
* [[Hormone replacement therapy]] | |||
* [[Estrogen receptor]] | |||
* [[Menopause]] | |||
== | ==References== | ||
{{Reflist}} | |||
[[Category:Estrogens]] | [[Category:Estrogens]] | ||
[[Category: | [[Category:Hormone replacement therapy]] | ||
[[Category: | [[Category:Steroid estrogens]] | ||
[[Category:Prodrugs]] | |||
<gallery> | |||
File:Estradiol succinate.svg|Estradiol hemisuccinate | |||
</gallery> | |||
Latest revision as of 01:42, 20 February 2025
A detailed overview of Estradiol hemisuccinate
| Estradiol hemisuccinate | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 123-94-4 |
| PubChem | 5282388 |
| DrugBank | DB13945 |
| ChemSpider | 4447590 |
| KEGG | D04078 |
Estradiol hemisuccinate is a synthetic estrogen and a derivative of estradiol, a naturally occurring hormone in the human body. It is used in hormone replacement therapy (HRT) and for other medical purposes. Estradiol hemisuccinate is an ester of estradiol, specifically the 3-hemisuccinate ester, which modifies the solubility and pharmacokinetics of the parent hormone.
Pharmacology[edit]
Estradiol hemisuccinate acts as an agonist of the estrogen receptor, mimicking the effects of endogenous estradiol. It is used to treat symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. The hemisuccinate ester form allows for different routes of administration, including oral and parenteral, and can influence the duration of action of the drug.
Medical Uses[edit]
Estradiol hemisuccinate is primarily used in hormone replacement therapy for menopausal women. It helps alleviate symptoms of estrogen deficiency and can also be used in the treatment of certain types of breast cancer and prostate cancer.
Side Effects[edit]
Common side effects of estradiol hemisuccinate include nausea, headache, breast tenderness, and weight gain. Long-term use of estrogen therapy has been associated with an increased risk of breast cancer, endometrial cancer, and cardiovascular disease.
Chemistry[edit]
The chemical structure of estradiol hemisuccinate is characterized by the addition of a succinate group to the estradiol molecule. This modification increases the water solubility of the compound, which can be advantageous for certain formulations and routes of administration.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
-
Estradiol hemisuccinate